NADAC acquisition cost data for BETAXOLOL 10 MG TABLET. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 10702001301 | $0.5831 | 2022-06-22 | Rx |
| 24658070001 | $0.5831 | 2022-06-22 | Rx |
| 42806003801 | $0.5831 | 2022-06-22 | Rx |
| 10702001301 | $0.5831 | 2022-06-22 | Rx |
| 24658070001 | $0.5831 | 2022-06-22 | Rx |
| 42806003801 | $0.5831 | 2022-06-22 | Rx |
| 10702001301 | $0.5831 | 2022-06-22 | Rx |
| 24658070001 | $0.5831 | 2022-06-22 | Rx |
| 42806003801 | $0.5831 | 2022-06-22 | Rx |
| 10702001301 | $0.5831 | 2022-06-22 | Rx |
Generic: Betaxolol HCl | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $2.4M | 29,992 | 8,106 | $6.23 |
| 2020 | $2.6M | 32,638 | 9,745 | $6.81 |
| 2021 | $2.5M | 30,780 | 8,545 | $6.70 |
| 2022 | $2.2M | 26,702 | 7,661 | $6.53 |
| 2023 | $2.1M | 26,423 | 7,458 | $6.16 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.